Analyzing Remedent (OTCMKTS:REMI) and Straumann (SAUHF)

Share on StockTwits

Straumann (OTCMKTS:SAUHF) and Remedent (OTCMKTS:REMI) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

Profitability

This table compares Straumann and Remedent’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Straumann N/A N/A N/A
Remedent -10.58% -7.23% -4.55%

Valuation & Earnings

This table compares Straumann and Remedent’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Straumann $1.13 billion 9.30 $277.36 million $17.82 37.15
Remedent $2.69 million 1.49 -$50,000.00 N/A N/A

Straumann has higher revenue and earnings than Remedent.

Analyst Recommendations

This is a summary of recent recommendations for Straumann and Remedent, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Straumann 0 0 0 0 N/A
Remedent 0 0 0 0 N/A

Risk & Volatility

Straumann has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500. Comparatively, Remedent has a beta of 0.25, meaning that its share price is 75% less volatile than the S&P 500.

Summary

Straumann beats Remedent on 8 of the 8 factors compared between the two stocks.

Straumann Company Profile

Straumann Holding AG provides tooth replacement solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, biomaterials, and digital solutions for use in tooth replacement and restoration or to prevent tooth loss. The company offers replacement solutions, including soft tissue level and bone level implants; SLActive surface for bone formation; Roxolid for use in dental implantology; and ceramic implants. It also provides prosthetic components and tools, as well as precision instruments, guided surgery tools, and handling components. In addition, the company offers digital solutions, including guided surgery, intra-oral scanning, and CADCAM; and oral tissue regeneration solutions comprising Emdogain, bone substitutes, membranes, soft tissue grafts, and fleeces. Further, it provides training and education services to its customers. The company offers its products to general dentists, specialists, and dental technicians/laboratories in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

Remedent Company Profile

Remedent, Inc., through its subsidiaries, researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. It also provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth leaving the patient's healthy tooth structure intact. In addition, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice, which enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. It sells its products to dental professionals in approximately 30 countries, including Europe, Asia, Latin America, the Pacific Rim, the Middle East, and the United States through dealers, as well as directly to the consumers through its internal sales force and third party distributors. The company was founded in 1986 and is headquartered in Ghent, Belgium.

Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.